222 related articles for article (PubMed ID: 31615542)
1. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Shanyinde M; Girardi E; Puoti M; De Luca A; Sighinolfi L; Caterina UF; Caramello P; Lampe FC; D'Arminio Monforte A; Cozzi-Lepri A;
BMC Public Health; 2019 Oct; 19(1):1291. PubMed ID: 31615542
[TBL] [Abstract][Full Text] [Related]
2. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.
Bilal U; Lau B; Lazo M; McCaul ME; Hutton HE; Sulkowski MS; Moore RD; Chander G
AIDS Patient Care STDS; 2016 May; 30(5):200-7. PubMed ID: 27158847
[TBL] [Abstract][Full Text] [Related]
3. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
[TBL] [Abstract][Full Text] [Related]
4. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.
Roux P; Cohen J; Lascoux-Combe C; Sogni P; Winnock M; Salmon-Ceron D; Spire B; Dabis F; Carrieri MP;
Drug Alcohol Depend; 2011 Jul; 116(1-3):228-32. PubMed ID: 21239121
[TBL] [Abstract][Full Text] [Related]
6. Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients.
Elliott JC; Aharonovich E; O'Leary A; Johnston B; Hasin DS
Alcohol Clin Exp Res; 2014 Dec; 38(12):3052-9. PubMed ID: 25581660
[TBL] [Abstract][Full Text] [Related]
7. Alcohol use among patients with HIV infection.
Bonacini M
Ann Hepatol; 2011; 10(4):502-7. PubMed ID: 21911892
[TBL] [Abstract][Full Text] [Related]
8. The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.
Kim HN; Crane HM; Rodriguez CV; Van Rompaey S; Mayer KH; Christopoulos K; Napravnik S; Chander G; Hutton H; McCaul ME; Cachay ER; Mugavero MJ; Moore R; Geng E; Eron JJ; Saag MS; Merrill JO; Kitahata MM
AIDS Behav; 2017 Jul; 21(7):1878-1884. PubMed ID: 28035496
[TBL] [Abstract][Full Text] [Related]
9. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
11. Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
Ferguson TF; Rosen E; Carr R; Brashear M; Simon L; Theall KP; Ronis MJ; Welsh DA; Molina PE
Alcohol Alcohol; 2020 Feb; 55(1):28-36. PubMed ID: 31812989
[TBL] [Abstract][Full Text] [Related]
12. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).
Yaya I; Marcellin F; Costa M; Morlat P; Protopopescu C; Pialoux G; Santos ME; Wittkop L; Esterle L; Gervais A; Sogni P; Salmon-Ceron D; Carrieri MP;
Nutrients; 2018 May; 10(6):. PubMed ID: 29857547
[TBL] [Abstract][Full Text] [Related]
13. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
[TBL] [Abstract][Full Text] [Related]
14. Past excessive alcohol consumption: a major determinant of severe liver disease among newly referred hepatitis C virus infected patients in hepatology reference centers, France, 2001.
Delarocque-Astagneau E; Roudot-Thoraval F; Campèse C; Desenclos JC;
Ann Epidemiol; 2005 Sep; 15(8):551-7. PubMed ID: 16117999
[TBL] [Abstract][Full Text] [Related]
15. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.
Neblett RC; Hutton HE; Lau B; McCaul ME; Moore RD; Chander G
J Womens Health (Larchmt); 2011 Feb; 20(2):279-86. PubMed ID: 21281111
[TBL] [Abstract][Full Text] [Related]
16. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.
Sullivan LE; Goulet JL; Justice AC; Fiellin DA
Drug Alcohol Depend; 2011 Sep; 117(2-3):158-63. PubMed ID: 21345624
[TBL] [Abstract][Full Text] [Related]
17. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.
Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB;
Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.
Leone S; Shanyinde M; Cozzi Lepri A; Lampe FC; Caramello P; Costantini A; Giacometti A; De Luca A; Cingolani A; Ceccherini Silberstein F; Puoti M; Gori A; d'Arminio Monforte A;
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):871-881. PubMed ID: 29318459
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.
Tetrault JM; Tate JP; Edelman EJ; Gordon AJ; Lo Re V; Lim JK; Rimland D; Goulet J; Crystal S; Gaither JR; Gibert CL; Rodriguez-Barradas MC; Fiellin LE; Bryant K; Justice AC; Fiellin DA
J Subst Abuse Treat; 2016 Sep; 68():62-7. PubMed ID: 27431048
[TBL] [Abstract][Full Text] [Related]
20. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
